beta-D-GlcpNAc-(1->6)-beta-D-Galp-(1->4)-D-Glcp

Term ID

CHEBI:148195

Synonyms

2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->6)-beta-D-galacto-hexopyranosyl-(1->4)-D-gluco-hexopyranose
2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->6)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
GlcNAc(b1-6)Gal(b1-4)Glc
N-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]oxan-3-yl]acetamide

Definition

An amino trisaccharide consisting of 2-acetamido-2-deoxy-β-D-glucopyranose, β-D-galactopyranose and D-glucopyranose residues joined in sequence by (1→6) and (1→4) glycosidic bonds.

References

glygen:G19529BG
glytoucan:G19529BG
kegg.glycan:G00561

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-GlcpNAc-(1->6)-beta-D-Galp-(1->4)-D-Glcp

Phenotype where environments contain beta-D-GlcpNAc-(1->6)-beta-D-Galp-(1->4)-D-Glcp

Phenotype modified by environments containing beta-D-GlcpNAc-(1->6)-beta-D-Galp-(1->4)-D-Glcp

Phenotype affecting beta-D-GlcpNAc-(1->6)-beta-D-Galp-(1->4)-D-Glcp

Human Disease Model